Maravai LifeSciences Holdings, Inc. MRVI Debt-to-equity

Debt-to-equity at other companies

Thermo Fisher ScientificTMO

0.7×0.0×

DanaherDHR

0.5×+0.2×

RepligenRGEN

0.3×+0.3×

Bio-Rad LaboratoriesBIO

0.1×-0.1×

Ginkgo BioworksDNA

1×+0.3×

Charles River LaboratoriesCRL

1.1×+0.2×

FAQ

What is Maravai LifeSciences Holdings, Inc.'s debt-to-equity?

Maravai LifeSciences Holdings, Inc. (MRVI) reported debt-to-equity of 0.9× in Q2 2026.

How has Maravai LifeSciences Holdings, Inc.'s debt-to-equity changed year-over-year?

Maravai LifeSciences Holdings, Inc.'s debt-to-equity decreased by 38.1% year-over-year, from 1.4× to 0.9×.

What is the long-term trend for Maravai LifeSciences Holdings, Inc.'s debt-to-equity?

Over 5 years (2020 to 2025), Maravai LifeSciences Holdings, Inc.'s debt-to-equity has grown at a -23.8% compound annual growth rate (CAGR), from 6.7× to 1.7×.

What does debt-to-equity mean?

Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.